SEARCH FILTERS
Time filter
Source Type

On August 2 starting at 1 p.m., Tom Guzik, Director of Digital Integration Services at IDEA, and Rob Consoli, Chief Revenue Officer at Liaison, will deliver a joint presentation: "EDI: The Advantages and Disadvantages of In-House vs. Outsource Mapping and Translation." This informative presentation will provide an overview of the pros and cons of handling integration needs in-house or on an outsourced basis and is a must-attend breakout session for IT, supply chain and business leaders in the electrical industry. "The Liaison-IDEA partnership provides electrical industry professionals the opportunity to access deep integration expertise and resources in a managed services model, all without the high costs and learning curve typically associated with application integration," said Consoli. "My team and I look forward to highlighting—both during the presentation and on the exhibit floor—the many benefits and possibilities of this partnership." The team will demonstrate how the Liaison ALLOYTM Platform, along with its managed services approach, facilitate all patterns of integration activities, including B2B, MFT, A2A, and hybrid integration. The platform's any-to-any translation capabilities, best-in-class mapping software, built-in data security, and ability to handle data from all sources in any format powers IDEA's IDX integration platform, giving electrical distributors and manufacturers the cutting-edge technology and expert resources they need to strengthen partner relationships and provide better service to customers. "Liaison's innovative approach to integration has given our customers a real competitive edge," said IDEA President and CEO Paul Molitor. "We hope to leverage this successful collaboration with Liaison at our upcoming conference to bring the benefits of IDX and cutting-edge cloud integration to even more organizations in the electrical industry space." Liaison's partnership with IDEA also gives users access to Liaison's LENS business activity monitoring tool. This tool provides a configurable interface, allowing users to set filters, create dashboard graphics and collect metrics. Access to Liaison's global support team, which provides unparalleled expertise, is also available to all IDEA customers. In addition, the partnership allows IDEA customers to benefit from ALLOY's unique microservices-based architecture and native support for all patterns of integration. A leader in cloud-based data solutions and one of the top B2B/EDI/VAN managed services providers in the world, Liaison gives organizations the technologies and support they require to meet today's toughest integration and data management challenges while creating a strong, data-centric foundation they can use to build a data-inspired future. Learn more about Liaison at www.liaison.com. About Liaison Technologies Liaison Technologies provides integration and data management solutions to help customers unlock the power of a data-centric approach to their business. Liaison's cloud-based approach breaks down the barriers between data silos to tap into the valuable information needed to make better decisions, faster. Tailored to solve complex data problems today while building a robust foundation for tomorrow's unforeseen challenges, Liaison fosters a seamless flow of information securely and at scale. Founded in 2000, Liaison serves more than 7,000 customers in 46 countries, with offices in the United States, the Netherlands, Finland, Sweden, the United Kingdom and Singapore. For more information, visit www.liaison.com and connect with Liaison on Twitter, LinkedIn and Facebook. About IDEA The Industry Data Exchange Association, Inc. (IDEA) is the official technology service provider and eBusiness standards body of the electrical industry. The company helps thousands of manufacturers and distributors find the most cost-effective methods for running day-to-day business. IDEA’s applications help connect the supply chain and make business processes efficient, easy and enjoyable for people every day. IDEA was founded in 1998 through a partnership rooted in the collective leadership of the National Electrical Manufacturers Association (NEMA) and the National Association of Electrical Distributors (NAED) members. Their applications also bring value to vertical markets such as industrial, plumbing and HVAC. IDEA is headquartered in Arlington, VA (idea4industry.com).


The students were attending a basketball clinic held on the school's outdoor basketball court, which debuted last year and is a joint endeavor between the BBVA Compass Foundation and the Kevin Durant Charity Foundation's Build It and They Will Ball court renovation program. The clinic was led by instructors from the Kevin Durant Youth Basketball Fantasy ProCamp, the two-day event for Austin-area youth that also started Thursday. Both the clinic and camp are being presented by BBVA Compass. "It's great to come back to IDEA Rundberg today with BBVA Compass and see how this court is being put to such good use," said Durant. "This is a place where the students can live big and bright and build their futures. It's an honor to be able to give back to Austin in a way that makes a real difference in day-to-day lives." Durant's appearance in Austin Thursday is his first in the city since winning the NBA Finals in June and being named MVP of the series. BBVA Compass' Summer of Opportunity initiative kicked off in June with employees across the bank's footprint handing out $25 gift cards to the people and organizations of their choice. The bank also summoned its brand ambassadors, including Durant, to help promote the summer-long campaign to spread bright cheer and pay it back to the communities it calls home. "This event today puts an exclamation point on our commitment to Austin," said Yolanda Davila, BBVA Compass' Community Relations Executive for Texas and also an IDEA board member. "We are out there every day helping families get into affordable homes, helping families build their futures, and it's nice to have such a phenomenal role model as Kevin come together with us during our Summer of Opportunity to help bring attention to those efforts and create such an amazing opportunity for the IDEA students." The BBVA Compass Foundation, which dedicated $100,000 to the court at IDEA Rundberg, helps carry out the bank's mission to be an engine of opportunity by broadening access to education and affordable housing, among other aims. The court is a vivid illustration of both the bank's dedication to Austin and the power of private industry to step in where other funding sources fall short. As a charter school, IDEA Rundberg receives approximately 75 percent of its funding from state and federal sources, compared to traditional public schools, and relies on private donations to pay for its facilities. IDEA's Austin Rundberg campus serves more than 700 students in its Academy and College Prep schools, and is part of the growing IDEA Public Schools network of charter schools serving more than 36,000 students across Texas. For the past 11 years, 100 percent of IDEA graduates have been accepted to college, including Ivy League schools and other highly competitive universities. "Our aim is to give the promising young people who walk through our doors whatever they need to build big futures, and we are marshaling all of the resources we can to help us achieve that," said IDEA Rundberg College Prep Principal Taylor Nichols. "We're proud to be able to stand with such committed partners in BBVA Compass and Kevin Durant in the service of that goal." To learn more about BBVA Compass, visit: www.bbvacompass.com For more news visit: www.bbva.com and newsroom.bbvacompass.com About BBVA Group BBVA is a customer-centric global financial services group founded in 1857. The Group is the largest financial institution in Spain and Mexico and it has leading franchises in South America and the Sunbelt Region of the United States; and it is also the leading shareholder in Garanti, Turkey's biggest bank for market capitalization. Its diversified business is focused on high-growth markets and it relies on technology as a key sustainable competitive advantage. Corporate responsibility is at the core of its business model. BBVA fosters financial education and inclusion, and supports scientific research and culture. It operates with the highest integrity, a long-term vision and applies the best practices. More information about BBVA Group can be found at bbva.com. About BBVA Compass BBVA Compass is a Sunbelt-based financial institution that operates 657 branches, including 342 in Texas, 89 in Alabama, 63 in Arizona, 61 in California, 45 in Florida, 38 in Colorado and 19 in New Mexico. BBVA Compass ranks among the top 25 largest U.S. commercial banks based on deposit market share and ranks among the largest banks in Alabama (2nd), Texas (4th) and Arizona (5th). BBVA Compass has been recognized as one of the leading small business lenders by the Small Business Administration (SBA) and ranked 5th nationally in the total number of SBA loans originated in fiscal year 2016. Additional information about BBVA Compass can be found at www.bbvacompass.com. For more BBVA Compass news, follow @BBVACompassNews on Twitter or visit newsroom.bbvacompass.com. About IDEA Public Schools IDEA Public Schools believes that each and every child can go to college. Since 2001, IDEA Public Schools has grown from a small school with 150 students to the fastest-growing network of tuition-free, Pre-K-12 public charter schools in the United States. Currently, the network serves nearly 36,000 college-bound students in 61 schools across three Texas regions. Additionally, IDEA boasts national rankings on The Washington Post and U.S. News & World Report's top high schools lists and is on-track to maintain its legacy of sending 100% of its graduates to college.


News Article | February 27, 2017
Site: www.prnewswire.co.uk

In seinem nunmehr siebten Jahr stellt der Productive Innovation Index (PII) die Pharmaunternehmen vor, die bei der Entwicklung und Kommerzialisierung innovativer Produkte am erfolgreichsten sind. Der Index stellt die folgende Grundfrage: Wenn man das gleiche Molekül in der frühen Phase zwei unterschiedlichen Unternehmen gäbe, welches würde das Beste daraus machen? Auf Grundlage einer systematischen, objektiven Analyse des Erfolgs jedes Unternehmens zwischen 2011 und 2016 kletterten 2017 einige große Pharmaunternehmen wieder in die Top 10. Sowohl Bristol-Myers Squibb als auch Merck verzeichneten einen kräftigen Anstieg, und mittelgroße Hersteller von Spezialprodukten zeigten wiederum eine starke Performance. Seit dem ersten Mal überhaupt führt Biogen den Index an. Johnson & Johnson, das in 5 der vergangenen 6 Jahre den Index anführte, zeigte erneut eine starke Performance, wurde aber aufgrund einer herausragenden Performance von Biogen, AbbVie und Gilead überholt. Mike Rea, CEO von IDEA Pharma, kommentierte den Index wie folgt: "Der alljährliche PII ist ein echtes Maß für die Innovation in der Pharmabranche -- sinnvolle Medikamente mit Patientennutzen. Die auffallendste Veränderung bei den F&E-Metriken 2016 gegenüber dem Vorjahr war der Rückgang bei den FDA-Neuzulassungen für Wirkstoffe: 22 in 2016 gegenüber 45 in 2015. Das hängt aber mit den Unternehmen zusammen, die die Zulassungen erhalten: Die Outperformer der vergangenen Jahre GlaxoSmithKline (GSK), Johnson & Johnson (J&J) und Novartis konnten 2016 kein einziges neuartiges Medikament zulassen. Das Gleiche gilt für Amgen, AstraZeneca (AZ), Bayer und Bristol-Myers Squibb (BMS). Insgesamt gingen sieben der 13 historischen großen Pharmaunternehmen, die 2015 noch 14 Zulassungen erhielten, 2016 leer aus. 14 der 22 Zulassungen gehen auf kleinere und möglicherweise agilere Unternehmen zurück, ein Zeichen für die zunehmende Bedeutung dieses Sektors. Wenn man genau hinschaut, zeigen sich verschiedene Trends. ‚Innovation' ist derzeit in der Branche nicht wirklich ein aussagekräftiger Begriff. Der Pharmaceutical Innovation Index zeigt, wer echten Patientennutzen liefert." Der PII beurteilt subjektive Maßstäbe für ‚Innovation' und bewertet Unternehmen anhand verschiedener Faktoren, darunter Geschwindigkeit der Markteinführung, Ausfallquote in den jeweiligen Phasen (insbesondere Phase III), Kostenübernahmequote, behördliche Zulassungen, Marktperformance und Einstufung durch Analysten. Unter PII auf unserer Website finden Sie nähere Informationen zum diesjährigen Pharmaceutical Innovation Index, zur Methodologie und zu den 30 Top-Unternehmen. Dort können Sie auch das Whitepaper herunterladen. Mit Fragen und Anregungen wenden Sie sich bitte an pii@ideapharma.com. Durch Wissen, und Erkenntnis und ausgeprägte Kreativität entfesseln wie das Potenzial eines jeden Moleküls und tragen aktiv dazu bei, dass die Pharmaindustrie Medikamente liefern kann, die einen Unterschied machen. Wir arbeiten in der frühen Lebenszyklusphase mit dem Kunden an einer Machbarkeitsstudie. Wir entwickeln eine überzeugende Produktstory und eine erstklassige Strategie, mit der jedes Molekül sein volles Potenzial erreichen kann. Das ist unsere Stärke. Und hier kann uns niemand etwas vormachen. Weitere Informationen finden Sie auf unserer Website oder besuchen Sie uns auf Facebook, LinkedIn und Twitter. Entwicklung des Vermarktungskonzepts für 7 der 10 (geplanten) Top-Produkte für die Onkologie bis 2020 // Positionierung von 3 der 11 Produkte, die von Reuters zu Blockbustern 2015 erklärt wurden, darunter die Top 2 // Entwicklung des Vermarktungskonzepts für 5 NMEs, die 2015 die FDA-Zulassung erhielten Weitere Informationen erhalten Sie von: Jess Spataro  Manager, Marketing, Brand & Communications  IDEA Pharma  Tel.: +1-212-929-7953 E-Mail: jess.spataro@ideapharma.com


News Article | February 27, 2017
Site: www.prnewswire.com

NEW YORK, February 27, 2017 /PRNewswire/ -- In seinem nunmehr siebten Jahr stellt der Productive Innovation Index (PII) die Pharmaunternehmen vor, die bei der Entwicklung und Kommerzialisierung innovativer Produkte am erfolgreichsten sind. Der Index stellt die folgende Grundfrage:...


News Article | February 28, 2017
Site: www.prnewswire.com

NEW YORK, February 28, 2017 /PRNewswire/ -- Maintenant dans sa septième année, l'indice d'innovation pharmaceutique (Pharmaceutical Innovation Index, PII) célèbre les sociétés pharmaceutiques les plus performantes en termes de développement et de commercialisation de l'innovation....


Patent
Idea Inc | Date: 2012-08-09

A chair that is reconfigurable between a folded and an unfolded configuration includes a first leg having an intermediate portion located between a first end and an opposite second end of the first leg and a second leg having an intermediate portion located between a first end and an opposite second end of the second leg. The intermediate portion of the second leg is pivotally connected to the intermediate portion of the first leg. A support member has a first end pivotally connected to the first leg and an opposite second end. A seat frame has a first portion pivotally connected to the second end of the support member and a second portion pivotally connected to the second end of the second leg. The second end of the support member is adjacent the first end of both the first and second legs in the folded configuration.


An electric double-layer capacitor is provided which is larger in electrostatic capacitance, and can be much higher in rated voltage, than that in the prior art using a liquid electrolyte solely composed of an ionic liquid. Having an electrolyte and electrodes, the capacitor incorporates an atom encapsulated fullerene or an atom encapsulated fullerene salt in the electrolyte. The electrolyte can either be a liquid solution or a solid. With the electrolyte being a solid, cations of the atom encapsulated fullerene or atom encapsulated fullerene salt may either be made movable or static in the electrolyte.


A device for manipulating colloidal particles in a bistable medium, the device includes a microcontroller, which stores a color and/or design scheme for a bistable medium, and a mechanism for changing the bistable medium from a first state to a second state.


Patent
Idea Inc | Date: 2015-09-25

The present invention is an improved system and method for analyzing multiple real estate properties. The system includes a pool of properties that are searched based on user-defined search criteria. The system identifies comparison properties from the search pool. The comparison properties include attributes that match or are a near match to the search criteria. The system compares each of the comparison properties to at least one average value and demonstrably depicts the comparison to the user.


News Article | February 27, 2017
Site: www.prnewswire.com

NEW YORK, February 27, 2017 /PRNewswire/ -- Now in its seventh year, the Pharmaceutical Innovation Index (PII) celebrates the pharmaceutical companies that are most successful at developing and commercialising innovation. The Index can be summarised by the question: if you gave...

Loading Idea Inc collaborators
Loading Idea Inc collaborators